Comparative Evaluation of Individualised Homoeopathic Medicines and Benzoic acid in Management of cases of Hyperuricemia- A Prospective Double Arm Study.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 68
- Locations
- 1
- Primary Endpoint
- To compare changes of pain levels in individualised group and benzoic acid group using VAS scale
Study Overview
Brief Summary
Comparing the role of Benzoic acid with individualised Homoeopathic medicine in managing the symptoms of hyperuricemia in adults in which Benzoic acid will be given to group A and individualised Homoeopathic medicine will be given to group B and each group will have 34 participants. VAS scale will be used to compare pain levels and serum uric acid levels will be tested at baseline, after 1 month upto 6 months
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- None
Eligibility Criteria
- Ages
- 19.00 Year(s) to 59.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Participants with SUA levels in males more than 7.0g/dl and females with SUA levels more than 6.0g/dl Participants may or may not be present with symptoms like joint pains, stiffness etc.
- •Participants willing to give consent.
Exclusion Criteria
- •Participants with unstable mental or psychiatric diseases, uncontrolled or severe systemic illness, autoimmune diseases, immunocompromised diseases.
- •Participants with joint deformities or chronic tophaceous gout (as these cases represent irreversible pathology) Participants with chronic kidney disease ( stage 3 or higher) or serum creatinine more than 1.5mg/dl Pregnant and lactating females Participants with renal complications ( SUA levels more than 13mg/dl).
Outcomes
Primary Outcomes
To compare changes of pain levels in individualised group and benzoic acid group using VAS scale
Time Frame: total 16 months study | enrollment period of 6 months | follow up of 6 months | data analysis 2 months | report writing 2 months | Vas scale to be used at baseline, 4 weeks upto 24 weeks
Secondary Outcomes
- To compare changes in symptomatology of hyperuricemia- frequency, intensity, stiffness and mobility in individualised group and benzoic acid group(total 16 months study)
Investigators
Dr Ritika Dhamija
Bakson Homoeopathic Medical college and Hospital